Apollo Commercial Real Estate Finance, Inc. Completes $3.0 Billion of Transactions in 2018
NEW YORK, Jan. 08, 2019 (GLOBE NEWSWIRE) — Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI) today […]
Caprion Biosciences Offers Mass Cytometry CRO Services to Advance Biomarker Discovery and Immune Monitoring
Mass cytometry services for pharmaceutical and biotechnology companies to accelerate development of new health insights SOUTH SAN FRANCISCO, Calif. and […]
ePlus Partners with Intel and Surgical Theater for 360° Virtual Reality Surgical Imaging
HERNDON, Va., Jan. 08, 2019 (GLOBE NEWSWIRE) — ePlus inc. (NASDAQ NGS: PLUS) today announced a new partnership with Intel […]
Lantronix CEO Jeff Benck Named “CEO of the Year” in Annual IoT Breakthrough Awards Program
2019 IoT Breakthrough Awards Recognize Standout Internet-of-Things Companies, Leaders and Products IRVINE, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) — Lantronix, […]
Altair to Present at Needham Growth Conference
TROY, Mich., Jan. 08, 2019 (GLOBE NEWSWIRE) — Altair (NASDAQ:ALTR) Chief Financial Officer Howard Morof will present at the 21st […]
TAOP Signs LOI to Acquire 51% of Shenzhen Taoping New Media Co., Ltd.
SHENZHEN, China, Jan. 08, 2019 (GLOBE NEWSWIRE) — Taoping Inc. (NASDAQ: TAOP), a leading provider of internet-based ad distribution and […]
Corvus Announces Enrollment in Second Arm of Phase 1/1b Dose-Escalation Trial of Anti-CD73 Antibody, CPI-006, Focused on Combination with CPI-444 Adenosine Antagonist
Both CPI-006 monotherapy and CPI-006 in combination with CPI-444 trial arms now enrolling patients at U.S. sites CPI-006 in combination with […]
FuelCell Energy Enters Into Option Agreement For Newport Beach, California Coyote Canyon Landfill Energy Redevelopment Project
DANBURY, Conn., Jan. 08, 2019 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq: FCEL), a global leader in delivering clean, innovative and […]
Dave & Buster’s Entertainment, Inc. to Participate in Two Investor Conferences
DALLAS, Jan. 08, 2019 (GLOBE NEWSWIRE) — Dave & Buster’s Entertainment, Inc., (NASDAQ:PLAY), (“Dave & Buster’s”), an owner and operator […]
SELLAS Life Sciences Provides Update on Late-Stage Immunotherapy Clinical Development Pipeline
Aligned with FDA on Phase 3 Registration-Enabling Trial for Galinpepimut-S (GPS) in Acute Myeloid Leukemia; Trial Expected to Start in […]
